Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes

BACKGROUND: The role of the antioxidant N-acetylcysteine (NAC) in the treatment of chronic obstructive pulmonary disease (COPD) has not been clarified as yet. In early studies, we found that the proportion of smokers with COPD having extremely slow/slow microsomal epoxide hydrolase (EPHX1) enzyme ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian-Qing, Zhang, Jia-Qiang, Liu, Hua, Zhao, Zhi-Huan, Fang, Li-Zhou, Liu, Ling, Fu, Wei-Ping, Shu, Jing-Kui, Feng, Jia-Gang, Dai, Lu-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437521/
https://www.ncbi.nlm.nih.gov/pubmed/25999707
http://dx.doi.org/10.2147/COPD.S79710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437521/
https://www.ncbi.nlm.nih.gov/pubmed/25999707
http://dx.doi.org/10.2147/COPD.S79710

Ejemplares similares